Immediate Impact
6 from Science/Nature 52 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Works of P Drouin being referenced
Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.
1998
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P Drouin | 120 | 135 | 79 | 103 | 61 | 544 | |
| Yang Xu | 225 | 59 | 57 | 99 | 34 | 630 | |
| J Bernheim | 132 | 95 | 23 | 45 | 35 | 460 | |
| Bülent Mızrak | 40 | 141 | 42 | 109 | 52 | 633 | |
| Hongmei Wang | 57 | 88 | 102 | 19 | 64 | 555 | |
| Xiaohua Fu | 40 | 49 | 57 | 65 | 54 | 648 | |
| Johannes Aufenanger | 51 | 204 | 57 | 116 | 37 | 577 | |
| Ayşe Kafkaslı | 53 | 73 | 45 | 103 | 37 | 487 | |
| Morteza Bagheri | 31 | 60 | 27 | 59 | 59 | 589 | |
| Claudiu Mărginean | 33 | 135 | 35 | 37 | 69 | 598 | |
| Elena Cojocaru | 82 | 124 | 32 | 18 | 95 | 596 |
All Works
Login with ORCID to disown or claim papers
Loading papers...